The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that ...
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The first big update to U.S. methadone regulations in 20 years is poised to expand access to the life-saving drug starting ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
A deal for Intel would be massive and come at a time when the chip maker is sputtering. Ted Colbert led the unit plagued by losses, production delays and the Starliner program that stranded two ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback